Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;14(3):141-7.

Novel MR imaging contrast agents for cancer detection

Daryoush Shahbazi-Gahrouei  1
Affiliations

Novel MR imaging contrast agents for cancer detection

Daryoush Shahbazi-Gahrouei. J Res Med Sci. 2009 May.

Abstract

Background: Novel potential MR imaging contrast agents Gd-tetra-carboranylmethoxyphenyl-porphyrin (Gd-TCP), Gd-hematoporphyrin (Gd-H), Gd-DTPA-9.2.27 against melanoma, Gd-DTPA-WM53 against leukemia and Gd-DTPA-C595 against breast cancer cells were synthesized and applied to mice with different human cancer cells (melanoma MM-138, leukemia HL-60, breast MCF-7). The relaxivity, the biodistribution, T(1) relaxation times, and signal enhancement of the contrast agents are presented and the results are compared.

Methods: After preparation of contrast agents, the animal studies were performed. The cells (2×10(6) cells) were injected subcutaneously in the both flanks of mice. Two to three weeks after tumor implantation, when the tumor diameter was 2-4 mm, mice were injected with the different contrast agents. The animals were sacrificed at 24 hr post IP injection followed by removal of critical organs. The T(1) relaxation times and signal intensities of samples were measured using 11.4 T magnetic field and Gd concentration were measured using UV-spectrophotometer.

Results: For Gd-H, the percent of Gd localized to the tumors measured by UV-spect was 28, 23 and 21 in leukemia, melanoma and breast cells, respectively. For Gd-TCP this amount was 21%, 18% and 15%, respectively. For Gd-DTPA-9.2.27, Gd-DTPA-WM53 and Gd-DTPA-C595 approximately 35%, 32% and 27% of gadolinium localized to their specific tumor, respectively.

Conclusions: The specific studied conjugates showed good tumor uptake in the relevant cell lines and low levels of Gd in the liver, kidney and spleen. The studied agents have considerable promise for further diagnosis applications of MR imaging.

Keywords: Contrast Agents; Early Detection of Cancer; Gadolinium; Imaging; Magnetic Resonance; Monoclonal Antibody.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:

Authors have no conflict of interests.

Figures

Figure 1
Figure 1
MR image signal intensity of washing solution of melanoma and other organs 24 hr after injection of different gadolinium compounds (n = 5).
Figure 2
Figure 2
MR image signal intensity of washing solution of leukemia and other organs 24 hr after injection of different gadolinium compounds (n = 5).
Figure 3
Figure 3
MR image signal intensity of washing solution of breast cells and other organs 24 hr after injection of different gadolinium compounds (n = 5).
See this image and copyright information in PMC

References

    1. Li G, Slansky A, Dobhal MP, Goswami LN, Graham A, Chen Y, et al. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjug Chem. 2005;16(1):32–42. - PubMed
    1. Lauterbur PC. Image formation by induced local interactions. Examples employing nuclear magnetic resonance. Clin Orthop Relat Res. 1989;(244):3–6. - PubMed
    1. Runge VM, Biswas J, Wintersperger BJ, Baumann SS, Jackson CB, Herborn CU, et al. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. Invest Radiol. 2006;41(3):244–8. - PubMed
    1. Colosimo C, Demaerel P, Tortori-Donati P, Christophe C, Van Buchem M, Hogstrom B, et al. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children. Pediatr Radiol. 2005;35(5):501–10. - PubMed
    1. Miura M, Micca PL, Fisher CD, Heinrichs JC, Donaldson JA, Finkel GC, et al. Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: biodistribution and toxicity in tumor-bearing mice. Int J Cancer. 1996;68(1):114–9. - PubMed

LinkOut - more resources